Russell Investments Group
FLGT icon

Russell Investments Group’s Fulgent Genetics FLGT Stock Holding History

Russell Investments Group’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.77M Buy
135,138
+41,657
+45% +$706K ﹤0.01% 1893
2026
Q1 		$1.48M Buy
93,481
+15,450
+20% +$335K ﹤0.01% 2028
2025
Q4 		$2.06M Sell
78,031
-21,566
-22% -$559K ﹤0.01% 1848
2025
Q3 		$2.24M Buy
99,597
+31,273
+46% +$644K ﹤0.01% 1798
2025
Q2 		$1.35M Buy
68,324
+39,418
+136% +$768K ﹤0.01% 1918
2025
Q1 		$490K Buy
28,906
+26,213
+973% +$446K ﹤0.01% 2300
2024
Q4 		$49.7K Buy
2,693
+1,960
+267% +$38.3K ﹤0.01% 2826
2024
Q3 		$15.9K Sell
733
-39,715
-98% -$888K ﹤0.01% 3000
2024
Q2 		$794K Buy
40,448
+682
+2% +$14.2K ﹤0.01% 2054
2024
Q1 		$863K Sell
39,766
-9,308
-19% -$231K ﹤0.01% 2022
2023
Q4 		$1.42M Sell
49,074
-17,133
-26% -$458K ﹤0.01% 1799
2023
Q3 		$1.77M Sell
66,207
-10,140
-13% -$346K ﹤0.01% 1617
2023
Q2 		$2.83M Buy
76,347
+31,173
+69% +$1.09M 0.01% 1363
2023
Q1 		$1.41M Buy
45,174
+12,342
+38% +$397K ﹤0.01% 1781
2022
Q4 		$978K Sell
32,832
-7,371
-18% -$264K ﹤0.01% 1980
2022
Q3 		$1.53M Buy
40,203
+39,933
+14,790% +$2M ﹤0.01% 1706
2022
Q2 		$14K Sell
270
-4,312
-94% -$237K ﹤0.01% 2828
2022
Q1 		$285K Sell
4,582
-588
-11% -$38.7K ﹤0.01% 2383
2021
Q4 		$519K Buy
5,170
+4,900
+1,815% +$431K ﹤0.01% 2434
2021
Q3 		$24K Sell
270
-633
-70% -$57.5K ﹤0.01% 2988
2021
Q2 		$86K Sell
903
-81,363
-99% -$6.5M ﹤0.01% 3075
2021
Q1 		$7.95M Sell
82,266
-245,813
-75% -$25.4M 0.01% 1088
2020
Q4 		$17.1M Sell
328,079
-71,055
-18% -$2.97M 0.03% 576
2020
Q3 		$16M Sell
399,134
-78,689
-16% -$2.46M 0.03% 565
2020
Q2 		$7.64M Buy
477,823
+192,544
+67% +$2.95M 0.02% 869
2020
Q1 		$3.07M Buy
285,279
+244,499
+600% +$3.41M 0.01% 1232
2019
Q4 		$524K Buy
40,780
+38,189
+1,474% +$454K ﹤0.01% 2380
2019
Q3 		$27K Buy
+2,591
New +$24.6K ﹤0.01% 2961

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
TG
TCW Group Los Angeles, California $14.9B AUM 46.29% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CMF
Counterpoint Mutual Funds San Diego, California $1.01B AUM 37.65% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return

Russell Investments Group's FLGT Position: Q2 2026 in Review

Russell Investments Group increased its Fulgent Genetics (FLGT) stake by 45% in Q2 2026, buying an estimated $706K and bringing the position to 135,138 shares worth $2.77M. The position accounts for ﹤0.01% of the portfolio, ranked #1893.

Russell Investments Group first reported a position in FLGT in Q3 2019 and has held it in 28 quarters since. The position peaked at $17.1M in Q4 2020. 50 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Russell Investments Group held 135,138 shares of Fulgent Genetics worth $2.77M as of Q2 2026.
  • Russell Investments Group bought 41,657 Fulgent Genetics shares in Q2 2026, an estimated $706K.
  • Fulgent Genetics made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #1893 holding.
  • Russell Investments Group first reported a position in Fulgent Genetics in Q3 2019 and has held it in 28 quarters since.
  • Russell Investments Group's Fulgent Genetics position peaked at $17.1M in Q4 2020.
  • 50 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.